Good Clinical Practice Compliance and the Start-up Company

| 01 May 2010

Start-up drug or device companies tend to minimize spending and occasionally to be "penny wise and pound foolish." However, when conducting clinical studies, rules must be followed to ensure the reliability of data. There are many pitfalls a start-up can fall into when first conducting clinical studies. These can be minimized or eliminated by planning the various items for a clinical study before execution and employing skilled and experienced individuals to monitor and audit the studies.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy